Literature DB >> 8640534

Cisplatin and derived anticancer drugs: mechanism and current status of DNA binding.

M J Bloemink1, J Reedijk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8640534

Source DB:  PubMed          Journal:  Met Ions Biol Syst        ISSN： 0161-5149


× No keyword cloud information.
  8 in total

1.  Development and application of a simple assay to quantify cellular adducts of platinum complexes with DNA.

Authors:  C Kloft; C Eickhoff; K Schulze-Forster; H R Maurer; W Schunack; U Jaehde
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

2.  Rearrangement of a 1,3-trans-[Pt(NH3)2[(GXG)-N7G,N7G]] intrastrand cross-link into interstrand cross-links within RNA duplexes.

Authors:  Marine Escaffre; Jean-Claude Chottard; Sophie Bombard
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

3.  Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy.

Authors:  Suzanne Leijen; Sjaak A Burgers; Paul Baas; Dick Pluim; Matthijs Tibben; Erik van Werkhoven; Enzo Alessio; Gianni Sava; Jos H Beijnen; Jan H M Schellens
Journal:  Invest New Drugs       Date:  2014-10-25       Impact factor: 3.850

Review 4.  Ruthenium-based chemotherapeutics: are they ready for prime time?

Authors:  Emmanuel S Antonarakis; Ashkan Emadi
Journal:  Cancer Chemother Pharmacol       Date:  2010-03-06       Impact factor: 3.333

5.  Gadolinium texaphyrin (Gd-Tex)-malonato-platinum conjugates: synthesis and comparison with carboplatin in normal and Pt-resistant cell lines.

Authors:  Jonathan F Arambula; Jonathan L Sessler; Mark E Fountain; Wen-hao Wei; Darren Magda; Zahid H Siddik
Journal:  Dalton Trans       Date:  2009-10-07       Impact factor: 4.390

6.  In silico approach to cisplatin toxicity. Quantum chemical studies on platinum(II)-cysteine systems.

Authors:  Henryk Chojnacki; Janina Kuduk-Jaworska; Iwona Jaroszewicz; Jerzy J Jański
Journal:  J Mol Model       Date:  2009-02-17       Impact factor: 1.810

7.  Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data.

Authors:  Sejin Park; Jihee Soh; Hyunju Lee
Journal:  BMC Bioinformatics       Date:  2021-05-25       Impact factor: 3.169

Review 8.  Emerging drug development technologies targeting ubiquitination for cancer therapeutics.

Authors:  Gianluca Veggiani; María Carla Rosales Gerpe; Sachdev S Sidhu; Wei Zhang
Journal:  Pharmacol Ther       Date:  2019-03-07       Impact factor: 12.310
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.